StemCell Therapy

Keynote address - Lord John Krebs - World Stem Cells Regenerative Medicine Congress
Lord John Krebs, chairman of the House of Lords Science and Technology Committee gives his presentation on #39;Mapping a route for the commercialisation of cell...

By: biopharmachannel

More here:
Keynote address - Lord John Krebs - World Stem Cells Regenerative Medicine Congress - Video

World Courier Logistics Ltd. - World Stem Cells Regenerative Medicine Congress 2013
We spoke with some of the sponsors at Europe #39;s largest stem cells and regenerative medicine industry conference. This is a three day congress that stages a s...

By: biopharmachannel

See the rest here:
World Courier Logistics Ltd. - World Stem Cells Regenerative Medicine Congress 2013 - Video

Health economics - Prof. Richard Lilford - World Stem Cells Regenerative Medicine Congress 2013
Prof. Richard Lilford, Clinical Epidemiology, Public Health Biostatistics at the University of Birmingham gives his presentation on #39;Health economics: how ...

By: biopharmachannel

See the rest here:
Health economics - Prof. Richard Lilford - World Stem Cells Regenerative Medicine Congress 2013 - Video

Alternative financing models - Navid Malik - World Stem Cells Regenerative Medicine Congress
Navid Malik, Head of Life Science Research at Cenkos Securities gives his presentation on #39;Alternative financing models: floating on the stock markets to gai...

By: biopharmachannel

Read the original here:
Alternative financing models - Navid Malik - World Stem Cells Regenerative Medicine Congress - Video

Chairman #39;s Opening Remarks - Prof. Chris Mason - World Stem Cells Regenerative Medicine Congress
Prof. Chris Mason from the Regenerative Medicine Bioprocessing Unit, Advanced Centre for Biochemical Engineering at the University College London gives the C...

By: biopharmachannel

Read more:
Chairman's Opening Remarks - Prof. Chris Mason - World Stem Cells Regenerative Medicine Congress - Video

The Science of Mesenchymal Stem Cells and Regenerative Medicine - Arnold Caplan PhD (Part 4)
In part 4, Prof. Caplan talks about isolating mesenchymal stem cells from bone marrow using specialized; calf serum choosing different assays to prove multip...

By: http://www.cellmedicine.com

Read more from the original source:
The Science of Mesenchymal Stem Cells and Regenerative Medicine - Arnold Caplan PhD (Part 4) - Video

The Science of Mesenchymal Stem Cells and Regenerative Medicine - Arnold Caplan PhD (Part 2)
In part 2, Prof. Caplan discusses the two types of regenerative medicine: tissue engineering and in vivo tissue regeneration, hematapoietic and mesenchymal s...

By: http://www.cellmedicine.com

Continue reading here:
The Science of Mesenchymal Stem Cells and Regenerative Medicine - Arnold Caplan PhD (Part 2) - Video

The Science of Mesenchymal Stem Cells and Regenerative Medicine - Arnold Caplan PhD (Part 1)
Professor Arnold Caplan of Case Western Reserve University is widely regarded as "The Father of the Mesenchymal Stem Cell". This lecture is a "must see" for ...

By: http://www.cellmedicine.com

See the original post:
The Science of Mesenchymal Stem Cells and Regenerative Medicine - Arnold Caplan PhD (Part 1) - Video

Tweet 



The meeting “Commercialization of Your Regenerative Medicine Research: Lessons from Spin Out Successes” was hosted by the Oxbridge Biotech Roundtable (OBR) (Oxford, UK) at the University of Oxford in February, 2013, and attracted a multi-stakeholder audience spanning academia and industry. 


The event featured case studies from Gregg Sando, CEO, Cell Medica (London, UK), John Sinden, CSO, Reneuron (Guilford, UK), and Paul Kemp, CEO and CSO, Intercytex (Manchester, UK). 


OBR is a student-led initiative with over 7000 members across eight different UK and US locations with a mission to foster a conversation about the healthcare and life sciences industry. 


Anna French and David A. Brindley, along with some of my assistance, captured and have now published the main themes of the meeting and the major questions facing the regenerative medicine industry and its rapidly emerging subsets of cellular and gene therapies. 


Notably, we discuss the compatibility of regenerative therapies to the existing healthcare infrastructure, biomanufacturing challenges (including scalability and comparability), and the amenability of regenerative therapies to existing reimbursement and investment models. Furthermore, we reiterate key words of advice from seasoned industry leaders intended to accelerate the translation path from lab bench to the marketplace.


To read the review see: Commercialization of Regenerative Medicine: Learning from Spin-Outs


Anna French, R. Lee Buckler, and David A. Brindley. Rejuvenation Research. April 2013, 16(2): 164-170. doi:10.1089/rej.2013.1423.

Source:
http://feedproxy.google.com/~r/CellTherapyBlog/~3/4Uv2o54_hWQ/commercialization-of-regenerative.html

Tweet 



The meeting “Commercialization of Your Regenerative Medicine Research: Lessons from Spin Out Successes” was hosted by the Oxbridge Biotech Roundtable (OBR) (Oxford, UK) at the University of Oxford in February, 2013, and attracted a multi-stakeholder audience spanning academia and industry. 


The event featured case studies from Gregg Sando, CEO, Cell Medica (London, UK), John Sinden, CSO, Reneuron (Guilford, UK), and Paul Kemp, CEO and CSO, Intercytex (Manchester, UK). 


OBR is a student-led initiative with over 7000 members across eight different UK and US locations with a mission to foster a conversation about the healthcare and life sciences industry. 


Anna French and David A. Brindley, along with some of my assistance, captured and have now published the main themes of the meeting and the major questions facing the regenerative medicine industry and its rapidly emerging subsets of cellular and gene therapies. 


Notably, we discuss the compatibility of regenerative therapies to the existing healthcare infrastructure, biomanufacturing challenges (including scalability and comparability), and the amenability of regenerative therapies to existing reimbursement and investment models. Furthermore, we reiterate key words of advice from seasoned industry leaders intended to accelerate the translation path from lab bench to the marketplace.


To read the review see: Commercialization of Regenerative Medicine: Learning from Spin-Outs


Anna French, R. Lee Buckler, and David A. Brindley. Rejuvenation Research. April 2013, 16(2): 164-170. doi:10.1089/rej.2013.1423.

Source:
http://feedproxy.google.com/~r/CellTherapyBlog/~3/4Uv2o54_hWQ/commercialization-of-regenerative.html

A KEY TO REGENERATIVE MEDICINE: Discovery of a new adult stem cell with special properties
Learn about the exciting discovery that could revolutionize regenerative medicine by providing a source to produce organs derived from a patient #39;s own stem c...

By: YourekaScience

Link:
A KEY TO REGENERATIVE MEDICINE: Discovery of a new adult stem cell with special properties - Video

Tweet 


The Alliance for Regenerative Medicine announced today the release of the 2013 annual regenerative medicine industry report.  Here is the announcement in the Wall Street Journal online.

I'm proud to have been a part of putting it together and hope people find it useful.  It is available for download on the ARM website here.  


In addition to the complete download, ARM will make many of the figures, charts,  tables and sections available for members to download and use in their own publications and presentations. Watch for these resources to be announced soon.

Source:
http://feedproxy.google.com/~r/CellTherapyBlog/~3/yFBYKblnudk/2013-annual-regenerative-medicine.html

Tweet 


The Alliance for Regenerative Medicine announced today the release of the 2013 annual regenerative medicine industry report.  Here is the announcement in the Wall Street Journal online.

I'm proud to have been a part of putting it together and hope people find it useful.  It is available for download on the ARM website here.  


In addition to the complete download, ARM will make many of the figures, charts,  tables and sections available for members to download and use in their own publications and presentations. Watch for these resources to be announced soon.

Source:
http://feedproxy.google.com/~r/CellTherapyBlog/~3/yFBYKblnudk/2013-annual-regenerative-medicine.html

Chicago Arthritis - What is Regenerative Medicine
Dr Tambar at Chicago Arthritis discusses regenerative medicine techniques, prp and stem cells, for arthritis and tendinitis.

By: ChicagoArthritis

Link:
Chicago Arthritis - What is Regenerative Medicine - Video

New Study at the Center for Regenerative Medicine - Mayo Clinic
The Center for Regenerative Medicine at Mayo Clinic investigates what advances of stem cell biology would be useful to apply in the treatment of patients with end stage diseases. Jorge Rakela, MD, associate director for the Center, provides an overview of the Center which is also involved in a tissue engineering program with Arizona State University. Jeffery Cornella, MD, a gynecological surgeon at Mayo Clinic, and Johnny Yi, MD, a surgical fellow at Mayo Clinic, talk about a study underway to develop new tissue to aid in the treatment of vaginal prolapse and other conditions.

By: mayoclinic

See the rest here:
New Study at the Center for Regenerative Medicine - Mayo Clinic - Video

Introduction to the Stanford Institute for Stem Cell Biology and Regenerative Medicine
Institute stem cell researchers Michael Longaker, Ravi Majeti, Renee Reijo Pera, Michael Clarke and Maximilian Diehn talk about research on regenerative medicine, cancer therapies and reproduction, and how clinical experiences motivate them to work even harder to find new therapies for disease.

By: institutesofmedicine

See the original post:
Introduction to the Stanford Institute for Stem Cell Biology and Regenerative Medicine - Video

Julia Greenstein Regenerative Medicine and Stem Cell Biology
This clip is part of the Career Girls ongoing series of career guidance/inspiration videos. See more at http://www.careergirls.org

By: careergirls

Excerpt from:
Julia Greenstein Regenerative Medicine and Stem Cell Biology - Video

How to understand stem cells - regenerative medicine
http://www.12hourmba.com 12 Hour MBA in Stem Cells The 12 Hour MBA in Stem Cells is an introductory level course designed to bridge gaps in your knowledge. It is most useful to new entrants, senior managers needing a big picture refresher, professional advisors and suppliers to the industry. We make it all easy -- leading you through the dynamics of stem cells, the main business drivers, giving you precious insight into where the money is made, stem cell development, commercialisation and ethics. In less than 12 hours you #39;ll: - Understand stem cells from bench to bedside - Discover where the money is made with stem cells - Understand risk and project management techniques for stem cells - Explore practices for stem cell product commercialisation - Learn about regulations, the government and the impact they can have - Consider the ethics of stem cells - Discover what the future holds for stem cells For more information, contact us at: http://www.terrapinntraining.com/contact-us.aspx

By: TerrapinnTraining

Read the rest here:
How to understand stem cells - regenerative medicine - Video

OTT: Breakfast Club Winter 2012 - Human Stem Cells 3.0: The Holy Grail of Regenerative Medicine
Human Stem Cells 3.0: The Holy Grail of Regenerative Medicine Techid: 12022

By: EmoryUniversity

Continue reading here:
OTT: Breakfast Club Winter 2012 - Human Stem Cells 3.0: The Holy Grail of Regenerative Medicine - Video

Stan Wang talks about creating non-embryonic stem for use n regenerative medicine
Gates Cambridge Scholar Stan Wang is pursuing a PhD in medicine supervised by recent Nobel Prize winner Sir John Gurdon. Stan works on a technique which takes tissue from any part the human body and gives it embryonic stem cell-like properties. This could have a huge impact on the world of regenerative medicine.

By: GatesCambridge

See original here:
Stan Wang talks about creating non-embryonic stem for use n regenerative medicine - Video